Elisabeth Mertin is a highly experienced professional in the pharmaceutical industry, currently serving as a Subject Matter Expert in Production at Ferring Pharmaceuticals since September 2024. Prior to this role, Elisabeth worked at medac GmbH as a Project Manager for QA Operations from October 2019 to September 2024, and held various positions at Ferring Pharmaceuticals between June 2018 and September 2019, including Manager of QA. Elisabeth's extensive expertise includes aseptic process risk assessments, contamination control strategies, and participation in a Bio-Decontamination Team. Elisabeth's earlier roles at Novartis involved senior management of quality projects, regulatory compliance, and technical supervision of manufacturing processes, with a solid educational background featuring a Master of Science in Molecular Biology and a Bachelor of Science in Biology from the University of Bayreuth.